CAT2F-Catalase

Added to your cart

CAT2F-Catalase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU CAT2F

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Catalase can be used for diagnostic applications in coupled assay systems e.g. to measure uric acid, or to remove hydrogen peroxide. BBI’s Catalase is available either extracted from bovine liver or from Aspergillus Niger fermentation. Native Catalase from Bovine Liver produces a highly activity enzyme. CAT2F is ideal if your application requires a highly active Catalase.
CAT2F

More information

Attributes

Description

  • Recommended Use
  • Diagnostic applications in coupled assay systems/ hydrogen peroxide removal
  • Lead Time
  • 6 weeks
  • Storage
  • Store desiccated at -15°C or below. Allow to come
  • Shelf Life
  • 6 months
  • Manufacturer Country
  • UK
  • Source
  • Bovine Liver
  • Activity
  • ≥11,700 U/mg material. (Approximately 40,000 U/mg protein).
  • EC Number
  • 1.11.1.6
  • EINECS
  • 232-577-1
  • Solubility
  • Dissolves readily at 5 mg/ml in 0.05M sodium/potassium phosphate buffer, pH 7.0 to give a clear solution.
  • Systematic Name
  • Hydrogen Peroxide: hydrogen peroxide oxidoreductase

Technical Documents

Product Specification (55.11KB)

Analytical Procedures (134.95KB)

Product Information (248.49KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox